We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+9.6%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$72.7B
AUM Growth
+$7.54B
(+12%)
Cap. Flow
-$3.34B
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
23.55%
Holding
2,585
New
253
Increased
940
Reduced
728
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$536M |
| 2 |
Procter & Gamble
PG
|
+$358M |
| 3 |
CSX Corp
CSX
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$186M |
| 5 |
Eli Lilly
LLY
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$370M |
| 2 |
American Electric Power
AEP
|
+$338M |
| 3 |
Alibaba
BABA
|
+$322M |
| 4 |
Prologis
PLD
|
+$307M |
| 5 |
HEICO Corp
HEI
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.03% |
| 2 | Financials | 13.75% |
| 3 | Industrials | 12.1% |
| 4 | Healthcare | 10.45% |
| 5 | Consumer Discretionary | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Enact Holdings
ACT
$6.62B
| $100K | ﹤0.01% |
2,708
-34,729
| -93% | -$1.23M |
|
|
ESGR
1652
DELISTED
Enstar Group
ESGR
| $100K | ﹤0.01% |
299
-6,658
| -96% | -$2.23M |
|
1653
Veeco
VECO
$3.27B
| $100K | ﹤0.01% |
+4,929
| New | +$97.3K |
|
1654
Winnebago Industries
WGO
$904M
| $100K | ﹤0.01% |
+3,452
| New | +$113K |
|
1655
Mirum Pharmaceuticals
MIRM
$6.36B
| $99K | ﹤0.01% |
1,962
-40
| -2% | -$1.78K |
|
1656
Tractor Supply
TSCO
$17.4B
| $99K | ﹤0.01% |
1,880
-18,470
| -91% | -$945K |
|
|
TTAN
1657
ServiceTitan Inc
TTAN
$8.21B
| $99K | ﹤0.01% |
+930
| New | +$104K |
|
1658
Alcon
ALC
$34.2B
| $98K | ﹤0.01% |
+1,126
| New | +$101K |
|
1659
CytomX Therapeutics
CTMX
$725M
| $98K | ﹤0.01% |
43,316
+42,500
| +5,208% | +$68.5K |
|
1660
Moog Inc Class A
MOG.A
$13B
| $98K | ﹤0.01% |
550
+21
| +4% | +$3.68K |
|
1661
Myomo
MYO
$41.3M
| $98K | ﹤0.01% |
+45,643
| New | +$165K |
|
1662
National Presto Industries
NPK
$973M
| $98K | ﹤0.01% |
1,009
+56
| +6% | +$4.89K |
|
1663
Procept Biorobotics
PRCT
$1.1B
| $98K | ﹤0.01% |
1,703
+810
| +91% | +$45.8K |
|
1664
Ubiquiti
UI
$34.4B
| $98K | ﹤0.01% |
240
-7
| -3% | -$2.55K |
|
1665
Corsair Gaming
CRSR
$1.18B
| $97K | ﹤0.01% |
+10,391
| New | +$83.8K |
|
1666
NiSource
NI
$20.4B
| $97K | ﹤0.01% |
2,428
-13,235
| -84% | -$519K |
|
1667
iShares Silver Trust
SLV
$30B
| $97K | ﹤0.01% |
2,983
-1,000
| -25% | -$30.6K |
|
1668
Frequency Electronics
FEIM
$780M
| $96K | ﹤0.01% |
4,254
+4,215
| +10,808% | +$78.1K |
|
1669
Viant Technology
DSP
$248M
| $94K | ﹤0.01% |
7,114
+637
| +10% | +$8.72K |
|
1670
MannKind Corp
MNKD
$1.26B
| $93K | ﹤0.01% |
24,935
+2,630
| +12% | +$11.6K |
|
1671
Innoviva
INVA
$1.52B
| $92K | ﹤0.01% |
+4,607
| New | +$88.6K |
|
1672
Angi Inc
ANGI
$189M
| $91K | ﹤0.01% |
5,980
+1,802
| +43% | +$26K |
|
1673
Arena Group
AREN
$73.8M
| $91K | ﹤0.01% |
+14,786
| New | +$72.6K |
|
1674
Arrowhead Research
ARWR
$12.7B
| $91K | ﹤0.01% |
+5,771
| New | +$82.8K |
|
1675
ImmunityBio
IBRX
$7.69B
| $91K | ﹤0.01% |
+34,788
| New | +$93.5K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Lazard Asset Management held 2,585 positions worth $72.7B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $3.34B in Q2 2025, closing 298 positions and reducing 728 holdings. Its most notable exit was Eastman Chemical, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, Lazard Asset Management opened a new position in Arcos Dorados Holdings worth $117M.
- Lazard Asset Management's largest Q2 2025 buy was Arcos Dorados Holdings: 14,873,278 shares worth $117M.
- Lazard Asset Management added most to Crown Castle in Q2 2025, an estimated $536M increase.
- Lazard Asset Management's biggest Q2 2025 reduction was NetEase, cutting an estimated $370M.
- Lazard Asset Management fully exited Eastman Chemical in Q2 2025, selling an estimated $13.1M.
- Lazard Asset Management's ten largest holdings make up 24% of its $72.7B portfolio in Q2 2025.
- Lazard Asset Management opened 253 new positions and closed 298 in Q2 2025.
- Lazard Asset Management's portfolio value rose 12% quarter-over-quarter to $72.7B.
Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.